Cannabinol (CBN) results from the break down of THC after its long exposure to oxygen and heat. CBN is mildly psychoactive, but not like its predecessor THC. CBN's anti-inflammatory properties make it a potential therapeutic agent for multiple sclerosis, rheumatoid arthritis, diabetes, allergic asthma, and Crohn's disease. By stimulating appetite, it can help treat cachexia, anorexia, and help those suffering from cancer or HIV/AIDS. CBN is also antibacterial, and when applied topically, it is effective in combatting MRSA. The topical application of CBN lowers ocular tension so it can reduce the risk and progression of glaucoma.
Out of all other cannabinoids, CBN is the most sedative, making it the most powerful cannabinoid for those who suffer from insomnia, sleep apnea, or other sleep disorders. CBN releases calcitonin and gene-related peptides from sensory nerves without impacting the CB1 or CB2 receptors. This means that it can reduce sensitivity to pain on its own, but that it can also work alongside CBD for enhanced pain relief. Research has shown CBN prolongs seizure latency in mice, making it a potential treatment for epilepsy and other seizure disorders. Lastly, CBN is an agonist of CB1 and CB2 receptors, so it is among the cannabinoids that stimulate bone growth, promote bone health, and help patients with bone diseases like osteoporosis.
This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer.